focus -WSS

focus

author：hotspot 2025-10-01 13:58:51 - browse：97492

PHILADELPHIA — Novo Nordisk, which has dominated the diabetes and obesity markets with its blockbuster drugs Ozempic and Wegovy, now also wants to be a major player in heart disease.

The landmark Select trial presented over the weekend — which showed Wegovy significantly cut the risk of heart complications — is just one of many efforts by the Danish drugmaker to expand into the cardiovascular space. It’s also developing several treatments specific to heart disease and is acquiring a medication for high blood pressure.

“We have a clear vision of being an established cardiovascular company, just as we see ourselves as leaders in diabetes and obesity,” Martin Lange, Novo’s executive vice president of development, said in an interview here at the American Heart Association conference.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hollywood unions extend contract negotiations for actors
Next article： FDA approves Moderna’s RSV vaccine, its second licensed product

hotspot

WSS

Delfi Diagnostics unveils key aspects of liquid biopsy test for lung cancer

'Little Tech' descents on D.C., wanting a say in how AI is regulated

Asahi Kasei to buy Calliditas, picking up kidney disease drug

Bird flu makes raw milk dangerous to consume, mouse study finds

STAT wants to know your pick for a great summer read or listen

The most pressing bird flu mysteries scientists want answered

hotspot

focus

Wikipedia

Novavax promises a turnaround & Lilly roils the obesity market

Illumina board agrees to spin off Grail, as divestment plans proceed

George Santos makes 1st court appearance after pleading not guilty to 13 counts

The Bio Revolution is changing business and society

New air purifier tech could be key to improving indoor air quality

Pharma’s losing bet in New Jersey

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Structure Therapeutics oral GLP

Malaria cases in Florida and Texas: Here’s what you need to know

Senators tussle over abortion against the backdrop of a presidential campaign

hotspot

Richard Slayman had a rejection episode of his pig kidney before leaving hospital

Medicare Advantage's lean provider networks lead CMS complaints

FTC loses bid to block Novant's North Carolina hospital merger

FDA approves Moderna’s RSV vaccine, its second licensed product

BD to buy Edwards patient monitoring unit for $4.2 billion

U.S. death rates show how politics are affecting public health

entertainment

knowledge

hotspot

hotspot